Valuation: Consun Pharmaceutical Group Limited

Capitalization 11.72B 13.47B 1.72B 1.46B 1.34B 1.27B 2.35B 160B 2.4B 15.69B 6.17B 77.16B 6.45B 6.32B 273B P/E ratio 2025
11.2x
P/E ratio 2026 * 9.46x
Enterprise value 8.73B 10.03B 1.28B 1.09B 996M 946M 1.75B 119B 1.79B 11.69B 4.6B 57.47B 4.8B 4.7B 203B EV / Sales 2025
3.15x
EV / Sales 2026 * 3.02x
Free-Float
50.22%
Yield 2025
4.59%
Yield 2026 * 5.3%
1 day-1.90%
1 week-5.99%
Current month-3.96%
1 month-2.32%
3 months-6.43%
6 months+6.17%
Current year+2.30%
1 week 15.92
Extreme 15.92
16.86
1 month 15.54
Extreme 15.54
17.57
Current year 15.3
Extreme 15.3
19.49
1 year 9.23
Extreme 9.23
19.49
3 years 4.31
Extreme 4.31
19.49
5 years 2.92
Extreme 2.92
19.49
10 years 2.61
Extreme 2.61
19.49
Manager TitleAgeSince
Chief Executive Officer 54 17/01/2024
Director of Finance/CFO 46 24/02/2025
Corporate Secretary 58 -
Director TitleAgeSince
Director/Board Member 86 24/12/2012
Director/Board Member 67 02/12/2013
Chairman 54 09/07/2021
Change 5d. change 1-year change 3-years change Capi.($)
-1.90%-5.99%+69.13%+225.87% 1.75B
-0.41%+0.83%-4.73%+67.61% 43.45B
+1.47%+0.33%+56.44%+139.68% 35.12B
-0.91%0.00%-18.86%+34.83% 10.83B
-0.79%+2.31%+12.62%+81.11% 10.26B
-4.34%-10.68%+55.89%+56.76% 9.61B
+0.82%+1.88%+40.63%+110.34% 8.73B
-1.14%0.00%+23.81%+67.31% 7.84B
-1.65%-5.45%+210.87%+406.90% 7.73B
+0.96%-3.19%+38.51%-10.14% 7.15B
Average -0.81%-1.73%+48.43%+118.03% 14.25B
Weighted average by Cap. -0.27%-0.69%+33.74%+102.18%

Financials

2025 2026 *
Net sales 3.43B 3.94B 503M 427M 391M 371M 686M 46.76B 701M 4.59B 1.8B 22.56B 1.89B 1.85B 79.72B 3.88B 4.46B 570M 483M 443M 421M 777M 52.97B 794M 5.2B 2.04B 25.56B 2.14B 2.09B 90.31B
Net income 1.09B 1.25B 160M 136M 124M 118M 218M 14.85B 223M 1.46B 573M 7.17B 599M 587M 25.33B 1.24B 1.43B 182M 155M 142M 135M 249M 16.97B 254M 1.67B 655M 8.19B 684M 670M 28.94B
Net Debt -2.99B -3.44B -439M -372M -341M -324M -599M -40.82B -612M -4B -1.58B -19.69B -1.65B -1.61B -69.6B -
Logo Consun Pharmaceutical Group Limited
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
Employees
3,115
Date Price Change Volume
20/04/26 16.00 $ -1.90% 1,048,000
17/04/26 16.31 $ -0.18% 1,204,000
16/04/26 16.34 $ -0.61% 1,329,834
15/04/26 16.44 $ -0.36% 1,604,963
14/04/26 16.50 $ 0.00% 863,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
13.93CNY
Average target price
21.45CNY
Spread / Average Target
+53.98%

Annual profits - Rate of surprise